China Health Group Inc. (8225.HK)
HKD 0.14
(1.41%)
HKD 0.14
(1.41%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -4.14 Million CNY | -1.97% |
| 2022 | -4.06 Million CNY | 64.27% |
| 2021 | -11.36 Million CNY | 22.66% |
| 2020 | -14.69 Million CNY | -238.47% |
| 2019 | -4.34 Million CNY | 42.15% |
| 2018 | -7.5 Million CNY | -19.91% |
| 2017 | -6.25 Million CNY | -177.57% |
| 2016 | 8.06 Million CNY | 1500.79% |
| 2015 | 504 Thousand CNY | -91.53% |
| 2014 | 5.95 Million CNY | -93.79% |
| 2013 | 95.88 Million CNY | 4.1% |
| 2012 | 92.1 Million CNY | -7.86% |
| 2011 | 99.96 Million CNY | -1.12% |
| 2010 | 101.09 Million CNY | 57.36% |
| 2009 | 64.24 Million CNY | 8.76% |
| 2008 | 59.07 Million CNY | 291.78% |
| 2007 | -30.8 Million CNY | -717.06% |
| 2006 | -3.77 Million CNY | 38.81% |
| 2005 | -6.16 Million CNY | 24.5% |
| 2004 | -8.16 Million CNY | 75.39% |
| 2003 | -33.15 Million CNY | -40.38% |
| 2002 | -23.61 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q3 | 8.13 Million CNY | 279.42% |
| 2023 Q4 | -4.14 Million CNY | -150.89% |
| 2023 Q2 | -4.53 Million CNY | -137.56% |
| 2023 FY | -4.14 Million CNY | -1.97% |
| 2023 Q1 | 12.07 Million CNY | 397.29% |
| 2022 FY | -4.06 Million CNY | 64.27% |
| 2022 Q3 | 12.74 Million CNY | 279.88% |
| 2022 Q1 | 17.02 Million CNY | 249.81% |
| 2022 Q4 | -4.06 Million CNY | -131.85% |
| 2022 Q2 | -7.08 Million CNY | -141.62% |
| 2021 Q2 | -11.58 Million CNY | -140.85% |
| 2021 Q4 | -11.36 Million CNY | 0.0% |
| 2021 FY | -11.36 Million CNY | 22.66% |
| 2021 Q1 | 28.35 Million CNY | 292.97% |
| 2020 Q1 | 8.45 Million CNY | 294.86% |
| 2020 FY | -14.69 Million CNY | -238.47% |
| 2020 Q2 | 2.38 Million CNY | -71.77% |
| 2020 Q4 | -14.69 Million CNY | 0.0% |
| 2019 FY | -4.34 Million CNY | 42.15% |
| 2019 Q4 | -4.34 Million CNY | 0.0% |
| 2019 Q2 | -459 Thousand CNY | -105.1% |
| 2019 Q1 | 9 Million CNY | 219.99% |
| 2018 FY | -7.5 Million CNY | -19.91% |
| 2018 Q4 | -7.5 Million CNY | 0.0% |
| 2018 Q2 | -4.3 Million CNY | 0.0% |
| 2017 Q4 | -6.25 Million CNY | 0.0% |
| 2017 Q1 | 1.75 Million CNY | -78.27% |
| 2017 FY | -6.25 Million CNY | -177.57% |
| 2017 Q2 | 8.92 Million CNY | 409.24% |
| 2016 Q2 | 6.92 Million CNY | 1.76% |
| 2016 Q1 | 6.8 Million CNY | 1249.21% |
| 2016 Q4 | 8.06 Million CNY | 0.0% |
| 2016 FY | 8.06 Million CNY | 1500.79% |
| 2015 Q2 | 4.94 Million CNY | 26.7% |
| 2015 FY | 504 Thousand CNY | -91.53% |
| 2015 Q1 | 3.9 Million CNY | -34.44% |
| 2015 Q4 | 504 Thousand CNY | 0.0% |
| 2014 Q1 | 3.97 Million CNY | -95.85% |
| 2014 Q4 | 5.95 Million CNY | 0.0% |
| 2014 Q2 | 97.97 Million CNY | 2364.24% |
| 2014 FY | 5.95 Million CNY | -93.79% |
| 2013 Q2 | 88.81 Million CNY | 1678.51% |
| 2013 Q4 | 95.88 Million CNY | 0.0% |
| 2013 FY | 95.88 Million CNY | 4.1% |
| 2013 Q1 | 4.99 Million CNY | 280.22% |
| 2012 Q4 | -2.77 Million CNY | 0.0% |
| 2012 FY | 92.1 Million CNY | -7.86% |
| 2011 Q4 | 99.96 Million CNY | 0.0% |
| 2011 FY | 99.96 Million CNY | -1.12% |
| 2011 Q2 | -22.68 Million CNY | 0.0% |
| 2010 FY | 101.09 Million CNY | 57.36% |
| 2010 Q4 | 101.09 Million CNY | 4951.01% |
| 2010 Q3 | -2.08 Million CNY | -25.62% |
| 2010 Q2 | -1.65 Million CNY | 0.0% |
| 2009 Q4 | 64.24 Million CNY | 0.0% |
| 2009 FY | 64.24 Million CNY | 8.76% |
| 2008 FY | 59.07 Million CNY | 291.78% |
| 2007 FY | -30.8 Million CNY | -717.06% |
| 2006 FY | -3.77 Million CNY | 38.81% |
| 2005 FY | -6.16 Million CNY | 24.5% |
| 2004 FY | -8.16 Million CNY | 75.39% |
| 2003 FY | -33.15 Million CNY | -40.38% |
| 2002 FY | -23.61 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Life Healthcare Group Limited | 5.23 Million HKD | 179.098% |
| China Biotech Services Holdings Limited | -106.5 Million HKD | 96.113% |